Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine.

about

Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine.

Item

http://www.wikidata.org/entity/Q38801087

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Predictors of relapse or maint ...... rm treatment with atomoxetine.

@en

type

Item

label

Predictors of relapse or maint ...... rm treatment with atomoxetine.

@en

prefLabel

Predictors of relapse or maint ...... rm treatment with atomoxetine.

@en

P1476

Predictors of relapse or maint ...... rm treatment with atomoxetine.

@en

P2093

Alexandra N Heinloth

http://www.w3.org/2001/XMLSchema#string

Chris Bushe

http://www.w3.org/2001/XMLSchema#string

Himanshu Upadhyaya

http://www.w3.org/2001/XMLSchema#string

Johannes Thome

http://www.w3.org/2001/XMLSchema#string

Laurence L Greenhill

http://www.w3.org/2001/XMLSchema#string

Ralf W Dittmann

http://www.w3.org/2001/XMLSchema#string

Rodrigo Escobar

http://www.w3.org/2001/XMLSchema#string

Sarah Lipsius

http://www.w3.org/2001/XMLSchema#string

Yoko Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.

Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial.

Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine.

Variability of response time as a predictor of methylphenidate treatment response in korean children with attention deficit hyperactivity disorder.

Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).

Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder.

Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD.

Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates.

Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure.

P2888

s12402-017-0227-8

P31

scholarly article

P356

10.1007/S12402-017-0227-8

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085189116

http://www.w3.org/2001/XMLSchema#string

P698

28477289

http://www.w3.org/2001/XMLSchema#string